SYRE – spyre therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Spyre Therapeutics Announces Grants of Inducement Awards
Spyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Spyre Therapeutics to Participate in Upcoming March Investor Conferences [Yahoo! Finance]
Spyre Therapeutics to Participate in Upcoming March Investor Conferences
Spyre Therapeutics, Inc. (NASDAQ: SYRE) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.
Form EFFECT Spyre Therapeutics, Inc.
Form POS AM Spyre Therapeutics, Inc.
Form 8-K Spyre Therapeutics, Inc. For: Feb 28
Form S-3 Spyre Therapeutics, Inc.
Form S-8 Spyre Therapeutics, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.